Weiss Multi Strategy Advisers LLC Bluebird Bio, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$26.16 - $63.5 $83,005 - $201,485	-3,173 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$46.96 - $61.67 $15,355 - $20,166	-327 Reduced 9.34%	3,173 $278,000
Q3 2019 Nov 14, 2019	BUY	$59.47 - $93.1 $59,470 - $93,100	1,000 Added 40.0%	3,500 $321,000
Q4 2018 Feb 14, 2019	SELL	$59.1 - $93.26 $236,400 - $373,040	-4,000 Reduced 61.54%	2,500 $248,000
Q3 2018 Nov 14, 2018	BUY	$88.86 - $117.49 $577,590 - $763,685	6,500 New	6,500 $949,000
Q1 2018 May 15, 2018	SELL	$105.8 - $150.94 $211,600 - $301,880	-2,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$81.25 - $130.7 $162,500 - $261,399	2,000	2,000 $356,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.